MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Intuitive Surgical Inc

Отворен

СекторЗдравеопазване

509.67 1.08

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

503.3

Максимум

513.24

Ключови измерители

By Trading Economics

Приходи

123M

688M

Продажби

374M

2.4B

P/E

Средно за сектора

72.947

57.333

EPS

2.21

Марж на печалбата

28.506

Служители

15,638

EBITDA

116M

810M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+16.53% upside

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-39B

168B

Предишно отваряне

508.59

Предишно затваряне

509.67

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

Intuitive Surgical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

22.04.2025 г., 20:55 ч. UTC

Печалби

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

23.01.2025 г., 21:41 ч. UTC

Печалби

Intuitive Surgical Posts Higher 4Q Profit, Revenue on Continued Procedure Growth

21.01.2025 г., 18:37 ч. UTC

Придобивния, сливания и поглъщания

Intuitive to Establish Direct Presence in Europe With Acquisition

18.10.2024 г., 15:22 ч. UTC

Печалби
Значими двигатели на пазара

Intuitive Surgical Shares Hit 52-Week High After 3Q Earnings, Revenue Beat Expectations

17.10.2024 г., 21:33 ч. UTC

Печалби
Значими двигатели на пазара

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Revenue Beat

17.10.2024 г., 20:56 ч. UTC

Печалби

Intuitive Surgical Posts 3Q Revenue Growth

22.04.2025 г., 20:13 ч. UTC

Печалби

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22.04.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 1Q EPS $1.92 >ISRG

22.04.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22.04.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 1Q Net $698.4M >ISRG

22.04.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22.04.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 1Q Rev $2.25B >ISRG

24.01.2025 г., 21:17 ч. UTC

Печалби

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

24.01.2025 г., 18:18 ч. UTC

Печалби

Intuitive Surgical Stock Drops After Earnings Beat. Wall Street Is Still Optimistic. -- Barrons.com

24.01.2025 г., 13:11 ч. UTC

Топ новини

Dow Jones Futures Fall Ahead Of Inflation Data; 5 Tech Giants To Buy And Watch -- IBD

24.01.2025 г., 09:51 ч. UTC

Горещи акции

Stocks to Watch Friday: Texas Instruments, CSX, Burberry, American Express -- WSJ

23.01.2025 г., 21:10 ч. UTC

Печалби

Intuitive Surgical Expects Non-GAAP Gross Profit Margin to Be Within 67% and 68% of Net Rev in 2025 >ISRG

23.01.2025 г., 21:09 ч. UTC

Печалби

Intuitive Surgical Expects Worldwide Da Vinci Procedures to Increase 13% to 16% in 2025 >ISRG

23.01.2025 г., 21:09 ч. UTC

Печалби

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 9,902 Systems as of Dec 31 >ISRG

23.01.2025 г., 21:05 ч. UTC

Печалби

Intuitive Surgical 4Q Adj EPS $2.21 >ISRG

23.01.2025 г., 21:05 ч. UTC

Печалби

Intuitive Surgical 4Q Da Vinci Surgical Systems Shipped 493.00 >ISRG

23.01.2025 г., 21:05 ч. UTC

Печалби

Intuitive Surgical 4Q Rev $2.41B >ISRG

23.01.2025 г., 21:05 ч. UTC

Печалби

Intuitive Surgical 4Q Net $685.7M >ISRG

23.01.2025 г., 21:05 ч. UTC

Печалби

Intuitive Surgical 4Q EPS $1.88 >ISRG

15.01.2025 г., 17:27 ч. UTC

Печалби

Intuitive Surgical Stock Jumps. 'Da Vinci' Robots Guide the Future. -- Barrons.com

6.01.2025 г., 12:00 ч. UTC

Топ новини

Healthcare Stocks Are Down and Out. Opportunities Abound. -- Heard on the Street -- WSJ

18.10.2024 г., 15:59 ч. UTC

Печалби

Intuitive Surgical Breaks Out On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

18.10.2024 г., 15:38 ч. UTC

Печалби

Intuitive Surgical Stock Pops on Earnings Beat. What Wall Street Thinks of the Results. -- Barrons.com

18.10.2024 г., 13:28 ч. UTC

Печалби

Intuitive Surgical Eyes Breakout On Massive Earnings Beat, But 2025 Launch Remains Key -- IBD

17.10.2024 г., 21:18 ч. UTC

Печалби
Значими двигатели на пазара

Intuitive Surgical Shares Rise 6% After 3Q Earnings, Rev Beat

Сравнение с други в отрасъла

Ценова промяна

Intuitive Surgical Inc Прогноза

Ценова цел

By TipRanks

16.53% нагоре

12-месечна прогноза

Среден 592.13 USD  16.53%

Висок 675 USD

Нисък 470 USD

Според 18 анализатори от Wall Street, предложили 12-месечна ценова цел за Intuitive Surgical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

18 ratings

15

Купи

3

Задържане

0

Продай

Техническа оценка

By Trading Central

489.52 / 517.31Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Weak Bullish Evidence

Дългосрочен план

Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.